Researchers invent a faster and more accurate test for diagnosing Zika

January 23, 2017, University of Texas Medical Branch at Galveston
Credit: University of Texas Medical Branch at Galveston

Researchers from The University of Texas Medical Branch at Galveston, in conjunction with the New York State Department of Health's Wadsworth Center, have developed a new detection test for Zika that is faster and more accurate than currently available tests. The new test can detect Zika in a very small sample of blood in less than four hours. The new test is detailed in EBioMedicine.

One of the obstacles to stemming the tide of the recent Zika outbreak has been the lack of a rapid, accurate that can quickly determine whether someone has been infected with the Zika virus or not. While there is a laboratory test called PCR that can determine the presence of Zika in blood samples, it is only reliable within the first week after someone has begun showing symptoms of the disease.

There is another test that measures antibodies that the body produces in response to infection that can be used after the contracting virus has disappeared in patients, but it may mistake a different virus from the same viral group for Zika. This group, called flaviviruses, includes yellow fever, dengue fever, West Nile and Japanese encephalitis viruses.

"The new diagnostic test was designed to more accurately detect Zika for a longer period of time after infection and reduce false positives due to cross reactivity with other flaviviruses," said Pei Yong Shi, UTMB professor in the department of biochemistry and molecular biology. "The technology has been jointly patented by UTMB and the Wadsworth Center. We anticipate that the , called a microsphere immunofluorescence assay or MIA, will soon be approved for use in a clinical setting."

Using samples from 153 patients with known Zika and/or dengue virus, the researchers demonstrated that the MIA test is more sensitive than the currently available tests in diagnosing Zika infection.

Susan Wong, laboratory director for Wadsworth Center's Diagnostic Laboratory, contacted Shi to see if they could combine their efforts to develop a better Zika assay.

"Shi and I have successfully collaborated on various projects for more than a decade," said Wong. "Our areas of expertise compliment one another."

"Our partnership with the Wadworth's Center is an excellent example of innovation that allows us to combine unique areas of expertise to advance this diagnostic test," said Sundeep Mattamana, director of the UTMB Office of Technology Transfer. "Our office is working closely with the technology transfer office at the Wadsorth Center to protect and commercialize this joint technology."

Explore further: Zika virus: Five things to know

More information: Susan J. Wong et al. A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis, EBioMedicine (2017). DOI: 10.1016/j.ebiom.2017.01.008

Related Stories

Zika virus: Five things to know

February 8, 2016
A concise "Five things to know about.... Zika virus infection" article for physicians highlights key points about this newly emerged virus in CMAJ (Canadian Medical Association Journal)

US regulators issue emergency authorisation for Roche Zika test: company

August 29, 2016
Swiss pharmaceutical giant Roche said Monday that US regulators had issued emergency authorisation to use its not-yet-approved diagnostic test for detecting the Zika virus in certain circumstances.

CDC allocates $184 million for Zika protection

December 22, 2016
(HealthDay)—Nearly $184 million has been earmarked to protect Americans against Zika virus infection, the U.S. Centers for Disease Control and Prevention announced Thursday.

First widely available Zika test OK'd for emergency use

April 29, 2016
The first commercial test for the Zika virus has been cleared for emergency use in the U.S. and could be available by next week.

CDC sends Florida 950 kits to test for Zika virus antibodies

February 9, 2016
Federal health officials have sent the state of Florida an additional 950 kits to test for viral antibodies in people who have shown Zika symptoms after traveling to affected countries.

Recommended for you

First proof a synthesized antibiotic is capable of treating superbugs

March 23, 2018
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesised and used to treat an infection for the first time—and could lead to the first new class of antibiotic drug in 30 years.

Scientists identify potential drug target in blood-feeding hookworms

March 22, 2018
In hookworms that infect and feed on the blood of mice, scientists have discovered a key step in blood digestion that can be targeted to disrupt the parasite's development and survival. These findings, published in PLOS Pathogens ...

Global burden of low back pain—a consequence of negligence and misinformation

March 21, 2018
A series of groundbreaking papers from Australian and international researchers in The Lancet, published today (22/3) warns that low back pain is a major health burden globally - across developed and developing nations - ...

Microscopic 'shuttles' transport enzyme from cells to trigger onset of kidney disease

March 21, 2018
A new study involving the University of Sheffield has identified a key culprit in the onset of kidney disease in a major marker for kidney disease development.

Metabolite therapy proves effective in treating C. difficile in mice

March 20, 2018
A team of UCLA researchers found that a metabolite therapy was effective in mice for treating a serious infection of the colon known as Clostridium difficile infection, or C. difficile.

Study of COPD patients has created a 'looking glass' into genome of pathogen

March 19, 2018
Decades of work on chronic obstructive pulmonary disease (COPD) at the University at Buffalo and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the pathogen that does ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.